Retatrutide just posted Phase 3 numbers that are hard to ignore.
~30% average body weight loss.
~70 pounds lost.
Even the lowest dose outperformed what used to be considered best-in-class.
But the most interesting part of the story isn't the weight loss.
It's the thousands of people already using grey-market Retatrutide before there's an approved pharmacy version available.
What did the trials actually do?
What dose produced the best balance of results and tolerability?
And why might the biggest risk have nothing to do with the drug itself?
PEPTIDES MASTERCLASS. A must listen if you’re peptide curious, peptide skeptical, bullish on peptides, or anti. The science, the uses, sourcing, concerns, and much more. @AbudBakri thank you for such an informative discussion.
There's an old idea that says a man is tested three times before he earns anything worth having. The first test takes what he loves. The second test takes his confidence. The third test makes him wait with no proof that it's coming. Most men fail the third one. Not because they're weak. Because patience with no guarantee is the hardest thing a human being can do. If you're in the waiting room right now, don't move. Don't panic. Just hold.